Our best wishes go out to Beth Evans, CCRA, on her retirement after 29 years at Duke Clinical Research Institute (DCRI). Since 2016, she has worked with ARLG as a lead CRA on many studies including  HABP/VABP, MDRO, SNAP, CRACKLE-2, POP, SHREC, and PHAGE.

“My passion was to work closely with site personnel, training them and guiding them through the day-to-day study activities,” Beth states. “I loved the details of each study and helping sites understand and follow the protocol. I was often called ‘Eagle Eyes’ for finding details others may have missed.”

In 2021, Beth channeled her passion and expertise into working on the PHAGE study with Drs. Robert “Chip” Schooley and Pranita Tamma to evaluate bacteriophages as a promising alternative to antibiotics. Her experience on the MDRO study as a site manager for the U.S. and Asia-Pacific regions was equally exciting as she traveled to provide study team training at multiple sites across China and Australia. “It was inspiring to see sites across the globe unite on one mission – the fight against antimicrobial resistance,” she states. “Given the growing threat of antibiotic-resistant bacteria, contributing to research that combats this global health issue is very important to me. ARLG is a world leader in the prevention and treatment of infections that could one day directly benefit me or someone close to me.”

Now that Beth has retired, she has no intention of sitting still. She will direct her passion and energy into hiking, paddleboarding, and playing tennis. During the next two years, she hopes to hike the tallest point in every U.S. state. When she isn’t outdoors, Beth plans to spend more time playing piano and may also take banjo lessons.